Loopio
Loopio continues to scale its operations with the addition of UK-based Avnio, bringing customers enhanced functionality, deeper integrations, and meaningful insights
LONDON, UK / ACCESSWIRE / May 18, 2023 / Today, Loopio, the leading response management software company, announced the acquisition of London-based software company and Request for Proposals (RFP) Response solution, Avnio.
With the acquisition of Avnio, Loopio will offer customers enhanced functionality to respond to and win more RFPs, and enable them to approach their response process more strategically by ensuring time is invested in the right opportunities. During these challenging economic times, the need to quickly and effectively respond to sales opportunities is more important than ever before.
"We're very excited about acquiring Avnio and realizing the potential that we will unlock for our customers. From day one, there was strong vision alignment with Avnio, and it was clear that their technology would complement our own," says Zak Hemraj, CEO and Co-founder of Loopio. "Avnio's deep integration with Salesforce, combined with our robust response workflows and analytics, will provide customers a stronger and smarter approach to their response process."
With the acquisition, Avnio CEO and Founder, Tobias Dawes, will be joining the Loopio team as Senior Vice President of Product and Design. This role appointment, in addition to Avnio's presence in the United Kingdom and India, will support Loopio in expanding its international footprint and better serve its growing global customer base. Coming off of a year where Loopio found that 39% of all top-line revenue was sourced by RFPs, the acquisition will ensure even more companies across the globe can realize the benefits of an optimized RFP response process.
"We are so excited and honored to join a team that shares our vision for a better response process," says Dawes. "This acquisition will undoubtedly propel our products and services to the next level. Together with Loopio, I am really excited about the value our customers will get from our two companies coming together."
Avnio, the only Salesforce-native RFP response platform, offers unique features that complement the Loopio platform, including functionality that enables its customers to combine their response data within their CRM, and industry-leading AI and GPT functionality.
For more information about Loopio's acquisition of Avnio, please visit the Loopio blog.
About Loopio
Loopio's response management platform helps companies streamline their response process for RFPs, DDQs, Security Questionnaires, and any sales request that comes their way. Currently serving over 1,300 companies globally at world-leading organizations, Loopio enables sales and proposal teams to respond faster, improve response accuracy, and win more business.
To learn more about Loopio, visit loopio.com and follow the company on LinkedIn.
About Avnio
Avnio is a Sales Control and Acceleration Platform dedicated to creating amazing solutions and products for sales teams. Avnio RFx is the only Salesforce native, fully-automated RFx solution designed to help you win more of the right business.
Contact Information
Sara Stratton
Senior Brand Communications Manager
sara.stratton@loopio.com
SOURCE: Loopio
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/755627/Loopio-Acquires-Avnio-Expanding-Global-Presence-and-Broadening-Enterprise-Capabilities
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom